Semathera
Latest round
- Seed
Last raised
- Jan 2017
Total raised
- $0.8M
Investors
- 1
About Semathera
Semathera Inc.Founded in 2016, Semathera Inc. is headquartered in Montreal, Canada, and specializes in creating treatments for diabetic retinopathy., Ltd, this investment marks a significant step in the company’s growth strategy.Semathera Inc. specializes in developing innovative biological traps that target semaphorin 3A (SEMA3A) and other cytokines implicated in diabetic retinopathy and diabetic macular edema. The company's core offerings are designed to bind and sequester SEMA3A, mitigating the detrimental effects associated with retinal inflammation, vascular leakage, and impaired vascular regeneration. Primary end users include hospitals, clinics, and research institutions focused on treating retinal degenerative diseases, particularly diabetes-related complications. Semathera's solutions have shown efficacy in various models of retinal vascular diseases, demonstrating potential in facilitating physiological re-vascularization and reducing avascular areas.Semathera’s revenue model revolves around partnerships and collaborations with pharmaceutical companies and research institutions, involving exclusive licensing agreements. Revenue generation is facilitated through the development and commercialization of their proprietary biological traps, aligning with the needs of healthcare providers addressing diabetic retinopathy. The firm engages in direct B2B transactions, where healthcare institutions procure their products for clinical use in treating patients, ensuring steady demand. These business transactions are characterized by structured agreements outlining collaboration terms, including potential milestone payments as product development progresses.Looking ahead, Semathera Inc., Ltd to support the development of new products targeting diabetic retinopathy. The company aims to expand into additional markets in Europe and North America, with a focus on regions that experience high rates of diabetes by the end of 2022.
Who invested in Semathera
1 investor across 1 round
See all investors in Semathera
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 11, 2017
Amount
$0.8M
Investors
Questions about Semathera
Who invested in Semathera?
Semathera has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Semathera raised?
Semathera has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Semathera last raise money?
Semathera's most recent round on record is a Seed, in Jan 2017.
What does Semathera do?
Semathera is a biotechnology company.
Where is Semathera headquartered?
Semathera is headquartered in Montreal, Canada.
Which VCs invest in companies like Semathera?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Semathera's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Semathera? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.